MorphoSys AG 뉴스 - MOR | 주식 나스닥

개인 투자자를 위한 전문가급 도구.

MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market

MorphoSys AG (FSE: MOR; NASDAQ: MOR) today announced that it has formally notified the Nasdaq Stock Market of its intention to voluntarily delist...

Kuehn Law Encourages DM, SHCR, MOR, and ALE Investors to Contact Law Firm

Kuehn Law Encourages DM, SHCR, MOR, and ALE Investors to Contact Law Firm PR Newswire NEW YORK, July 8, 2024...

MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders

MorphoSys AG (FSE: MOR; NASDAQ: MOR) today announced that the company has entered into a delisting agreement with Novartis BidCo AG and Novartis...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

UpTickMeA$AP 6 월 전

SCHEDULE 13D

Novartis BidCo Germany AG

Shared Voting Power
34,337,809

Percent of Class Represented by Amount in Row (11)
91.17%

The calculation of the foregoing percentage is based on 37,662,738 outstanding bearer shares (“Shares”) with no-par value (and excluding Shares held in treasury) of MorphoSys AG (the “Issuer”).

https://fintel.io/doc/sec-novartis-ag-1340243-sc-13da-2024-june-21-19895-8490

👍️0

ipo_dude 11 월 전

PIPELINE ALONE reportedly worth $30usd/share.. then 30 million float. 1 million short. Plenty of cash!!’

👍️0

Monksdream 1 년 전

Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc

👍️0

TenKay 7 년 전

MPSYY Froward Split 2 for 1.

http://otce.finra.org/DailyList

👍️0

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

MorphoSys AG (MOR)

개인 투자자를 위한 전문가급 도구.

MOR 뉴스

MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market

Kuehn Law Encourages DM, SHCR, MOR, and ALE Investors to Contact Law Firm

MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

MOR Discussion

최근 히스토리

회사 소개

사업

Popular

앱 받기

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

MorphoSys AG (MOR) 뉴스

MorphoSys AG (MOR)

개인 투자자를 위한 전문가급 도구.

MOR 뉴스

MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market

Kuehn Law Encourages DM, SHCR, MOR, and ALE Investors to Contact Law Firm

MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

MOR Discussion

최근 히스토리

회사 소개

사업

Popular

앱 받기